 CELLESTIS LIMITED Company Summary
|
| Cellestis is a listed Australian biotechnology company commercializing QuantiFERON(R) technology for diagnosing tuberculosis and other diseases worldwide. QuantiFERON(R)-TB Gold tests for the presence or absence of a protein (gamma-interferon) produced by a patient's white blood cells after stimulation with specific tuberculosis proteins. The test has received regulatory and policy approvals in the USA, Japan, Europe and elsewhere. The Company operates through subsidiaries in the USA, Europe, Australia and Japan. |
|
| Company Data |
 |
Fax |
03 9571 3544 |
|
|
Principal Sector |
Health & Pharm |
|
|
Principal Industry |
Biotechnology |
|
|
Listed |
2001/04/24 |
|
|
Homepage |
www.cellestis.com |
|
| |
|
|
